A truncated derivative of the phage endolysin LysK containing only the CHAP (cysteine-and histidinedependent amidohydrolase/peptidase) domain exhibited lytic activity against live clinical staphylococcal isolates, including methicillin-resistant Staphylococcus aureus. This is the first known report of a truncated phage lysin which retains high lytic activity against live staphylococcal cells.
Staphylococcus aureus is associated with a variety of clinical manifestations, ranging from skin infections to more acute conditions such as necrotizing pneumonia and septicemia (20) . Since methicillin-resistant S. aureus (MRSA) is now the most commonly reported antibiotic-resistant bacterium in clinical settings (5) , the development of alternative antimicrobials is warranted.
Bacteriophage-encoded endolysins are a group of enzymes that act by digesting the peptidoglycan of bacterial cell walls. The potential of these molecules for controlling bacterial infections and preventing the pathogenic colonization of mucosal membranes has been demonstrated previously (2, 6, 10, 11, 14, 15, 21, 23, 29) . In general, phage endolysins have a modular organization with an N-terminal catalytic domain and a Cterminal cell-binding domain (9, 12, 18) . To our knowledge, only a few phage endolysins, such as LysK, phi11, MV-L, and LysH5, have been reported to lyse live staphylococcal cultures (4, (25) (26) (27) . LysK has a modular structure similar to the structure of these endolysins, with two catalytic domains, a CHAP (cysteine-and histidine-dependent amidohydrolase/peptidase) domain and a central amidase-2 domain (N-acetylmuramoyl-L-alanine amidase), as well as a C-terminal SH3b cell-binding domain (4, 22, (25) (26) (27) .
In this study, we examined the involvement of each of the three domains of LysK during exolysis by performing a deletion analysis and identified truncated LysK proteins containing only the CHAP domain, which still showed lytic activity against live clinical staphylococcal isolates, including MRSA. In previous studies other workers have obtained similar results upon deletion of the cell wall-binding domains (1, 8, 16, 17, 19) . Construction of a single-domain protein for therapeutic purposes is desirable since, as well as facilitating protein production, this may decrease the likelihood of a significant immunogenic response. Unlike antibiotics, intact endolysins are large proteins which are capable of stimulating a humoral immune response, especially when they are used intravenously (7, 24, 30) .
Generation of deletion derivatives of LysK. LysK protein deletion mutants were constructed based on the domain organization of this protein. The primer pairs used for domain deletion analysis were FLysK plus Rami (CHAP and amidase-2), Fami plus RSH3b (amidase-2 and SH3b), Fami plus Rami (amidase-2), FSH3b plus RSH3b (SH3b), and FLysK plus R313 to R156 (CHAP) ( Table 1) . Amplified products were cloned into the pQE60 (Qiagen) expression system and transformed into Escherichia coli XL1-Blue for expression. Cells were induced as previously described (3). However, induction was performed at 26°C for 14 h to avoid inclusion bodies.
CHAP domain exhibits lytic activity against heat-killed staphylococcal cells. Preparation of protein samples, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and zymographic analysis were performed as previously described (13, 26) . Zones of lysis on the zymogram gel were used as an indication of putative catalytic activity. The results suggested that in the absence of other domains, the LysK CHAP domain retains lytic activity, while the amidase-2 and SH3b domains appear to have no significant lytic activity when they are expressed alone or in combination (Fig. 1) .
To determine the smallest fully functional catalytic region of LysK, a sequential deletion analysis of the CHAP domain was performed (Fig. 1, plasmids C203 to C156 ). Zymogram analysis indicated that while there was some residual activity with a shorter variant with only 159 amino acids (C159), full endopeptidase activity required amino acids 1 to 162 (C162), suggesting that the N-terminal CHAP domain is sufficient for lysis of S. aureus, including MRSA. In addition, the truncated derivatives showed a spectrum of inhibition similar to that of LysK, lysing all S. aureus strains tested, including MRSA, heterogeneous vancomycin-intermediate S. aureus, and other antibiotic-resistant variants (data not shown), but not lysing members of genera other than Staphylococcus among the strains tested.
CHAP domain exhibits lytic activity against live cells. The native LysK protein and two derivatives of interest, C203 (CHAP and six residues of amidase-2) and C165 (CHAP) (Fig.  1) , were selected to determine the lytic activity against live staphylococcal cells. LysK and C165 were purified by ion-exchange and size exclusion chromatography, while C203 was purified by nickel affinity chromatography (unpublished data). The specific activity of each protein was estimated as previously described (2, 23) , with some modifications. Briefly, MRSA strain DPC5645 (Moorepark Food Research Centre Culture Collection) was grown to an optical density at 590 nm (OD 590 ) of 0.3, centrifuged, and then resuspended to a final OD 590 of 0.8 in 50 mM sodium acetate buffer (pH 6.5). Serial dilutions of 100 l purified lysin were mixed with 100 l of the bacterial suspension and incubated at 37°C. The amount of lysin that reduced the OD 590 by 50% in 15 min was defined as 1 U of activity. The protein concentration was measured using a Bradford protein assay kit (Bio-Rad). Based on the data obtained, the specific activities of LysK, C165, and C203 were calculated to be 34 U nmol Ϫ1 (621 U mg Ϫ1 ), 68 U nmol Ϫ1 (3,690 U mg Ϫ1 ), and 2.4 U nmol Ϫ1 (100 U mg Ϫ1 ), respectively. Increases and decreases in activity were determined as previously described (1) . Compared to the activity of LysK, the activity of C165 was approximately twofold higher, demonstrating that a LysK derivative containing only the CHAP domain is more active against live staphylococcal cells than the native enzyme. By contrast, the activity of C203 was approximately 14-fold lower, which may have been due to a change in protein folding. It should also be emphasized that while C165 did not contain a His tag, the native protein and C203 did contain such a tag, which potentially could have altered its specific activity. Nonetheless, the results show that C165 had high activity in this case. To compare the catalytic activities, DPC5645 cells were treated with the same quantity (0.5 nmol) of LysK, C203, and C165 (Fig. 2) .
LysK (26) , phi11 (4), MV-L (27) , and LysH5 (25) are the only staphylococcal endolysins that have been reported to kill untreated staphylococcal cells. However, deletion of additional domains of phi11 changed it to a barely active lysin (4, 28) , and while the LysK derivatives lyse cells of all members of the genus Staphylococcus, MV-L and LysH5 have only been shown to lyse S. aureus, as well as Staphylococcus simulans and Staph- 
